fda ruling on tirzepatide Says Compounded Must Exit the Market Tirzepatide Update: On December 19th

Clinical studies of certain FDA-approved weight management medications have shown meaningful weight loss for many patients when medication is combined with a reduced-calorie diet and increased physical activity

For women with chronic digestive disorders that disrupt nutrition or increase systemic inflammation, BPC-157 may be included in an approach to optimize the metabolic and immune landscape for conception and early pregnancy

For nutrition players, time is of the essence: the user base for GLP-1 drugs will continue to expand

For more background on how this treatment works across the week, the GLP-1 explainer is worth a look